3136 results for «3016»
3136 results
EuroPCR 2021 Hotlines / Late-Breaking Trials in physiology: FAST II, TARGET FFR, P3, OLV Pullback, France PCI, and more!
27 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in imaging:
- Angiography based Fractional Flow Reserve: the FAST II trial
- Instantaneous wave-free ratio for the assessment of nonculprit lesions
- Capacity of the PPG to predict functional revascularisation
- Clinical impact of FFR guided PCI
Revascularisation for chronic coronary syndrome and multivessel disease (Part 1) - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation, to appraise how to select the optimal revascularisation strategy in such patients and to learn how to perform state-of-the-art PCI to achieve optimal procedural outcomes.
This session was originally presented...
Revascularisation for chronic coronary syndrome and multivessel disease - Part 2
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation and to appraise how to select the optimal revascularisation strategy in such patients.
This session was originally presented during EuroPCR 2021.
Multivessel disease revascularisation: balancing the risk
19 May 2021 – From EuroPCR 2021
Watch this session presented by Jean Fajadet, Thomas Cuisset, Bruno Farah, Marek Grygier, Maciej Lesiak and Sylwia Iwanczyk in order to understand the selection of PCI for multivessel disease patients, to demonstrate the best treatment strategy for patients presenting with multivessel disease, and to discuss DAPT strategy in multivessel...
Challenges and opportunities in high-risk patients undergoing TAVI
19 May 2021 – From EuroPCR 2021
Watch this session presented by Marco Valgimigli, Raul Moreno and Peter Nordbeck in order to discuss the designing TAVI trial for high-risk patients, the timing of TAVI and PCI, as well as the balance between thrombosis prevention and bleeding mitigation
Diffuse Coronary Artery Disease: RESTORE DCB – THE HYPER STUDY
18 May 2021 – From EuroPCR 2021
Watch this session presented by Alfonso Lelasi in order to have an update on the treatment of diffuse CAD involving small vessels and/or bifurcation with a novel hybrid (DES and DCB) approach, to understand the rationale of The HYPER Study (NCT03939468), and to know more about third generation RESTORE...
XLIMIT - Randomised controlled trial to assess endothelisation of Xlimus DES
18 May 2021 – From EuroPCR 2021
Watch this session presented by Luca Testa in order to know about XLIMIT randomised clinical trial, and to learn about Xlimus DES stent with Sirolimus and bioabsorbable polymer coating.
Edge-to-edge mitral valve repair : contemporary indications and techniques - Session with LIVE demonstration
20 May 2021 – From EuroPCR 2021
Watch this session if you want to get updated on current indications and technique of edge-to-edge mitral valve repair.
This session was originally presented during EuroPCR 2021.
TAVI: contemporary indications and techniques - Session with LIVE case
20 May 2021 – From EuroPCR 2021
Watch this session if you want to reflect on lifetime management of patients with severe aortic stenosis.
This session was originally presented during EuroPCR 2021.
EuroPCR 2021 Hotlines / Late-Breaking Trials: CLASP, CHOICE-MI, CHOICE-MI MAC, TENDER, and Global EXPAND
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in mitral valve replacement & repair:
- 2-year outcomes for transcatheter mitral repair from the CLASP study
- The choice of optimal transcatheter treatment for mitral insufficiency registry
- Outcomes of patients treated for mitral annulus calcification
- TENDER - TENDyne European expeRience registry: Early outcome
- Safety...
EBC Main: Behind the curtain
18 May 2021 – From EuroPCR 2021
Watch this session presented by David Hildick-Smith in order to have additional information about the EBC main trial, to learn about the principal investigator's interpretation of results, and to find out about the European Bifurcation Club's remaining questions to be addressed in future trials.
TAVI outcomes in women with small annuli
18 May 2021 – From EuroPCR 2021
Watch this session presented by Thomas Modine, Nicole Karam and Sabine Bleiziffer to learn more about the latest studies regarding TAVI outcomes in women with small annuli, and to discover the results of self-expanding supra-annular TAVI compared to SAVR in this population.
Endovascular aortic repair and case-based discussion of complications during peripheral interventions (Part 2)
20 May 2021 – From EuroPCR 2021
This session, which was originally broadcast during EuroPCR 2021, presents 6 cases of unexpected complications of large vessel access in the context of TAVI procedures and enables our experts to discuss their successful management, using a variety of techniques. It highlights the need for a large...
A Cypher implanted 15 years ago
24 May 2019 – From EuroPCR 2019
Consult this session to discover a LIVE demonstration from Institut Cardiovasculaire Paris Sud - Massy, France, regarding Cypher implantation. The patient here is a 85 years-old female with a Cypher implanted 15 years ago, presenting now with exertional angina. Angiogram shows long LAD stenosis. Watch the...
TAVI in a bicuspid aortic valve
24 May 2019 – From EuroPCR 2019
A Medina 0,1,0 lesion
24 May 2019 – From EuroPCR 2019
Intermediate risk TAVI
23 May 2019 – From EuroPCR 2019
Opening - LIVE demonstration from National University Heart Centre Singapore
04 Jul 2019 – From AICT-AsiaPCR 2019
Diffuse multivessel disease
05 Jul 2019 – From AICT-AsiaPCR 2019
PCR e-Course 2020 Closing Ceremony: reinventing education in interventional cardiovascular medicine!
28 Jun 2020 – From PCR e-Course 2020
On behalf of the Core Team and the 271 e-Faculty members, Davide Capodanno, Jean Fajadet and William Wijns thank those who attended and participated in - as well as contributed to - PCR e-Course 2020. At a time when exchange with peers and extended networks like...